Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to monitor the transcutaneous bilirubin (TCB) level in healthy near-term and full-term neonates from birth to 30 days of age across China. The main question it ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neonatal-Infant Brain and Behavior Development Network
Collaborators
NCT03866213 · Hyperbilirubinemia, Neonatal, Jaundice, Neonatal
NCT06209489 · Newborn Jaundice, Hyperbilirubinemia, Neonatal, and more
NCT06324799 · Newborn; Vitality, Hyperbilirubinemia, Neonatal
NCT06238349 · Hyperbilirubinemia, Neonatal
NCT04251286 · Hyperbilirubinemia, Neonatal
Guangzhou Women and Children's Medical Center,
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions